Final-Program-ATS-2023-AP.vp

246

TUESDAY • MAY 23

P1209 Lemierre’s Syndrome Complicated By Tension Hemothorax In The Setting Of The Concomitant Use Of Intrapleural Fibrinolytics And Systemic Anticoagulation/ L. Benes, New York, NY P1210 Talc-Induced Acute Renal Failure After Talc Pleurodesis/ G. Collins, New Orleans, LA P1211 Tunnel Vision: A Novel Approach to Use Cryotherapy Through a Flexible Bronchoscope to Restore the Patency of a Chest Tube Occluded by a Blood Clot/ F. Figueroa Rodriguez, Oklahoma City, OK P1212 Candida Empyema In A Patient With Adenocarcinoma Of Gastroesophageal Junction/ K. Kaur, Johnson city, TN P1213 A Rare Case of Empyema Associated With Pancreatic Pseudocyst-induced Esophagopleural Fistula/ J. Mak, Galveston, TX P1214 Rare Case of Complicated Parapneumonic Effusion Secondary to Perihepatic Abscess/ S. Lashani, Rancho Mirage, CA P1215 Spontaneous Bacterial Empyema (SPEM) With Concurrent Spontaneous Bacterial Peritonitis (SBP) In Liver Cirrhosis/ M.U.Z. Mirza, Lahore, Pakistan P1216 Not Your Typical Chest Pain: A Case of Complicated Costosternal Septic Arthritis With Extensive Chest Wall And Mediastinum Extension/ C.J. Merino Gualan, Norwalk, CT P1217 Xanthogranulomatous Pyelonephritis Leading to Empyema: A Renal Cell Carcinoma Mimic/ J. Renz, Pueblo, CO P1218 A Case of Bronchopleural Fistula Formation Following Acute Pulmonary Embolism and Empyema/ J. Emberson, Wichita, KS P1219 Loculated Parapneumonic Effusion: Diagnosis Per Point-of-Care Ultrasound/ C. Howdeshell, Spokane, WA P1220 Rare Necessities: Two Cases Of Successful Nonoperatively Managed Empyema Necessitans/ R. Auth, Providence, RI P1221 Tuberculous Empyema: Combined Intrapleural Therapy Might Be an Alternative/ P. Colares, Sao Paulo, Brazil P1222 The Cryptic Case of a Pleural Effusion: Cryptococcosis as an Isolated Empyema/ S. George, Cleveland, OH P1223 Aspergillus a Rare Cause of Empyema/ T. Roy, Stratford, NJ

P174 Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Improves Lung Function, Symptoms, Quality of Life and Reduces Exacerbation Rate and Risk in the Enhance-1 Phase 3 Trial of Ensifentrine in COPD/ F.C. Sciurba, Pittsburgh, PA P175 Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Significantly Improves COPD Symptoms and Quality of Life in the Phase 3 Enhance-1 Trial/ F.C. Sciurba, Pittsburgh, PA P176 Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Significantly Reduces Annualized Exacerbations and Delays the Time to First Exacerbation in COPD: Pooled Sub-Group Analyses of Enhance-1 and Enhance-2 Phase 3 Trials/ I. Barjaktarevic, Los Angeles, CA

CLINICAL THEMATIC POSTER SESSION

C41

A “PLEUR”ALITY OF ISSUES: CASE REPORTS IN PLEURAL DISEASE DIAGNOSTICS AND MANAGEMENT

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area L, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

P1201 Chest Tube Placement Into a Giant Bulla/ S. Kim, Saint Louis, MO P1202 A Young HIV Positive Male Smoker Presenting With Giant Bullous Emphysema Complicated By Secondary Spontaneous Pneumothorax/ R. Khan, Philadelphia, PA P1203 Spontaneous Pneumomediastinum In A Young Man/ A. Mukherjee, New Brunswick, NJ P1204 Bilateral Tension Pneumothorax In A Woman Causing Cardiac Arrest/ A. Mukherjee, New Brunswick, NJ P1205 Poland Syndrome and Pneumothorax/ P. Nguyen, Atlanta, GA P1206 Pneumomediastinum, Pneumopericardium and Bilateral Pneumothorax: A Rare Complication of Seizure/ S. Shireen Kanamgode, Worcester, MA P1207 Hidden Agenda: A Case of Osteomyelitis Disguised as Pneumothorax Ex Vacuo/ J.E. Fesen, New Orleans, LA P1208 An Unintentional Connection: Pneumothorax and Alveolopleural Fistula as an Uncommon Complication of Intrapleural TPA/DNase Administration for Empyema in the Setting of Necrotizing Pneumonia/ M.C. Manjunath, Brighton, MA

ATS 2023 • Washington, DC